Healios K.K. (OTCMKTS:HLOSF) Short Interest Up 347.0% in January

by · The Cerbat Gem

Healios K.K. (OTCMKTS:HLOSF – Get Free Report) saw a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 663,299 shares, a growth of 347.0% from the January 15th total of 148,399 shares. Based on an average daily trading volume, of 140 shares, the short-interest ratio is presently 4,737.9 days. Based on an average daily trading volume, of 140 shares, the short-interest ratio is presently 4,737.9 days.

Healios K.K. Price Performance

OTCMKTS HLOSF remained flat at $2.10 on Friday. Healios K.K. has a fifty-two week low of $1.90 and a fifty-two week high of $4.45. The firm has a fifty day moving average price of $2.10 and a 200-day moving average price of $3.21.

About Healios K.K.

(Get Free Report)

Healios K.K. is a Tokyo–based biotechnology company focused on the development and commercialization of regenerative medicine products and services. The company’s core expertise lies in induced pluripotent stem cell (iPSC)–derived therapies, with a pipeline that includes retinal pigment epithelium (RPE) cells for age‐related macular degeneration and neural cell products targeting neurological disorders. Healios operates a specialized cell processing center in Chuo‐ku, Tokyo, adhering to stringent quality standards for clinical‐grade cell manufacturing.

Beyond its proprietary programs, Healios provides contract development and manufacturing services (CDMO) to pharmaceutical and research institutions.

Further Reading